BOT - Anything but charting, page-4585

I do like their hyperhidrosis numbers though! They say over 15 million Americans have hyperhidrosis (so say BOT too). Lots of these go undiagnosed or fail to seek treatment. They say only 18% of that number get diagnosed - that's 2.7m people (BOT have said they have a target market of 3.7m people which includes a share of undiagnosed). They also quote the International Hyperhidrosis Society (IHHS) estimating one in three U.S. adults (85.2 million) are bothered by excessive underarm sweating (maybe that's where BOT think they reach some more).

Just going off the 18% number who are diagnosed (2.7m) - if only half seek treatment that's 1.35m individuals (in the US alone). If BOT only won over 10% of that market (135,000 people) who each spent $550/mnth on SB, then there stands gross revenue of $74m PER MONTH (Euroz Hartley have been using the $100m figure, per annum). If more than half of diagnosed hyperhidrosis suffers seek help, and +10% of them go with SB, seems to me that this mob really reaffirm what BOT have been saying all along about potential market share!